| Literature DB >> 36233658 |
Mario Pacilli1, Giovanna Pavone1, Alberto Gerundo1, Alberto Fersini1, Antonio Ambrosi1, Nicola Tartaglia1.
Abstract
Bleeding after total thyroidectomy remains a rare event that affects early postoperative morbidity, occurring in 0.3% to 4.2% of cases. Intraoperative bleeding is an unpleasant complication, and it is often easily manageable, although postoperative bleeding may represent a life-threatening condition for the patient. The purpose of our study was to clarify the role of the Valsalva manoeuvre to reduce postoperative bleeding. Between January 2019 to February 2022, 250 consecutive patients were listed for thyroid surgery at our surgical department. The study cohort consisted of 178 patients, divided into two groups based on the execution of the Valsalva manoeuvre. There was no difference in the duration of surgery between groups. Group B had fewer reinterventions for bleeding. Group A had a significantly greater volume of drainage output than Group B. Cervical haematoma can compromise a patient's life, so bleeding control is crucial. Our results show that using a simple and safe Valsalva manoeuvre can improve the postoperative course with a significant reduction in drainage output, but does not prevent the risk of reoperation for hemorrhage.Entities:
Keywords: Valsalva manoeuvre; bleeding; hemostasis; surgical drains; thyroidectomy
Year: 2022 PMID: 36233658 PMCID: PMC9571820 DOI: 10.3390/jcm11195791
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Figure 1STROBE flowchart.
Demographic data. BMI (Body Mass Index) and ASA score (American Society of Anesthesiologists). Significance tests include T tests for numerical variables and chi-square tests for categorical variables. A p value less than 0.05 was considered statistically significant.
| Group A ( | Group B ( | Overall ( | ||
|---|---|---|---|---|
| Age (Range) | 20–74 | 18–74 | 18–74 | |
| Mean | 47.82 | 45.51 | 46.75 | 0.143 |
| Median (±SD) | 49.5 (±14.49) | 45.5 (±14.28) | 48 (±14.36) | |
| M/F | 37/59 | 28/54 | 65/113 | 0.543 |
| BMI (Range) | 19–40 | 20–41 | 19–41 | |
| Mean | 25.23 | 25.25 | 25.24 | 0.501 |
| Median (±SD) | 26 (±4.08) | 22 (±4.99) | 25 (±4.55) | |
| ASA score | ||||
| I | 38/96 | 35/82 | 63/178 | 0.675 |
| II | 58/96 | 47/82 | 115/178 | |
| Multinodular Goiter | 60/96 | 49/82 | 109/178 | 0.708 |
| Grave’s disease | 11/96 | 11/82 | 22/178 | 0.692 |
| Malignant | 25/96 | 22/82 | 47/178 | 0.905 |
| Hashimoto’s thyroiditis | 6/96 | 5/82 | 11/178 | 0.966 |
Surgical and post-surgical data. The chi-square significance test was used. A p value less than 0.05 was considered statistically significant.
| Group A ( | Group B ( | ||
|---|---|---|---|
| Operation length (min) | 126.11 | 126.78 | 0.416 |
| Recovery room stay (min) | 126.93 | 123.96 | 0.083 |
| Reoperation (<6 h) | 6/96 | 1/82 | 0.085 |
| Reoperation (<24 h) | 4/96 | 0/82 | 0.125 |
| Drainage volume (mL) | 79.38 | 56.67 | <0.001 |
| Permanence of drainages beyond the first postoperative day | 16/96 | 5/82 | 0.029 |
| Hospital stay (days) | 2.22 | 2.15 | 0.175 |
Correlation tests. Phi coefficients were calculated for associations between dichotomous variables. Point-biserial correlations were calculated for correlations between dichotomous and continuous variables. A p value less than 0.05 was considered statistically significant.
| Φ Value | ||
|---|---|---|
| Reoperation (<6 h) | −0.129 | 0.914 |
| Reoperation (<24 h) | −0.140 | 0.938 |
| Permanence of drainages on the second day | −0.163 | 0.970 |
| Drainage volume (mL) | −0.851 | <0.001 |
Binary logistic regression.
| B | S.E. | Exp (B) | 95% C.I. | |||
|---|---|---|---|---|---|---|
| Lower | Upper | |||||
| Drainage Volume | −0.462 | 0.136 | 0.630 | 0.482 | 0.822 | <0.01 |
| Constant | 11.803 | 2.909 | 133,703.033 | <0.01 | ||
Most important complications during TT.
| Group A ( | Group B ( | ||
|---|---|---|---|
| Wound infection | 2/96 | 1/82 | 0.655 |
| Transient postoperative | 14/96 | 9/82 | 0.474 |
| Transient recurrent laryngeal nerve Palsy, | 2/96 | 2/82 | 0.873 |